RTI
Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of
orthopedic, dental, hernia and other biologic implants, donated nearly
500 spinal allografts to AIC-CURE International Children’s Hospital in
Kijabe, Kenya this week.
The allograft implants will be used for spinal fusions to treat
congenital spinal deformities, limb defects and vertebral reconstruction
for tuberculosis infection in Kenyan children. Without surgical
reconstruction, spines affected by tuberculosis often collapse and
paralyze those affected. In addition, limb defects and impediments make
life difficult and limit opportunities for these children to grow and
reach their full potential.
“This donation has allowed us to reach new heights of surgical
reconstruction in Kenya,” said Timothy C. Mead, MD, medical director of
CURE Kenya. “Without RTI’s support, our potential would not be as great
and fewer children would have their lives transformed through successful
surgery.”
AIC-CURE International Children’s Hospital has provided life-changing
surgeries to more than 22,000 Kenyan children since 1998.
“Our mission at RTI is to improve lives through biologic solutions to
achieve life-restoring and life-saving results,” said Brian K.
Hutchison, chairman and CEO for RTI. “Through the generous gift of
tissue donation, RTI is able to provide these allografts to children in
need.”